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Malaria merupakan penyakit bawaan parasite yang utama di dunia dan bertanggung 
jawab terhadap 214 juta jangkitan setiap tahun, dan menyebabkan lebih daripada 
438,000 kematian. Di Sudan, Plasmodium falciparum merupakan parasit utama yang 
menyebabkan malaria. Polimorfisme gen sitokin boleh merubah pembangunan protein 
ini dan oleh itu memberi kesan kepada gerak balas imun terhadap jangkitan malaria. 
Interferon- (IFN- ), sitokin pro-inflamasi telah terbukti mempunyai kesan antiparasit 
dan imunopatogenik semasa jangkitan malaria. Polimorfisme nukleotida tunggal 
(SNP), + 874T /A, dalam intron pertama gen IFN-telah menunjukkan hubungan 
dengan kerentanan manusia terhadap banyak penyakit termasuk malaria di sesetengah 
populasi. Oleh itu, tujuan kajian ini adalah untuk mengkaji sama ada variasi genetik 
pada lokus IFNG (IFN- +874T/A gene) berkait rapat dengan jangkitan malaria 
Plasmodium falciparum dalam kalangan komuniti Sudan. Tiga puluh empat sampel 
darah kering populasi Sudan dari Kem IDP Ardamata di Al-Geneina Town, Sudan 
disahkan terlebih dahulu sama ada positif malaria dan berasal daripada jangkitan 
Plasmodium falciparum atau tidak menggunakan kaedah PCR bersarang. PCR 
kemudian digunakan untuk mengetahui hubungan antara jangkitan P. falciparum dan 
polimorfisme gen IFN- + 874T/A. Keputusan ujian PCR bersarang menunjukkan 
bahawa daripada 34 sampel yang dianalisis, 17 sampel adalah positif terhadap 
jangkitan P. falciparum manakala 17 sampel lagi adalah negatif. Walau bagaimanapun, 
tidak ada hubungan yang signifikan antara gen IFN- + 874T/A dengan jangkitan P. 
falciparum. Sebagai kesimpulan, data ini menawarkan titik permulaan untuk analisis 
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fungsional dan genetik wilayah genom IFN-γ dalam jangkitan malaria dalam kalangan 
penduduk Sudan, yang dapat merangsang kepada pembangunan vaksin malaria yang 




DETECTION OF IFN- γ +874T/A GENE POLYMORPHISM 
AND Plasmodium falciparum INFECTION IN ARDAMATA IDP 




Malaria is the primary parasite disease and is responsible for around 214 million 
infections annually, resulting in more than 438,000 deaths. In Sudan, Plasmodium 
falciparum is typically accountable for severe malaria. Cytokine gene polymorphisms 
can alter the development of these proteins and therefore affect the immune response 
to disease. Interferon- (IFN- ), a pro-inflammatory cytokine, has been shown to have 
antiparasitic and immunopathogenic effects during malaria infection. A single 
nucleotide polymorphism (SNP), +874T/A, in the first intron of the IFN- gene, has 
presented associations with human susceptibility to many diseases, including malaria 
in certain populations. Therefore, the purpose of this study was to investigate whether 
genetic variation at the IFNG locus (IFN-+874T/A gene) affects susceptibility to P. 
falciparum malaria infection in the Sudanese population. Thirty-four (34) dried blood 
samples of Sudanese communities from the Ardamata IDP Camp in Al-Geneina Town, 
Sudan were first confirmed with nested PCR for malaria positive confirmation and 
Plasmodium falciparum identification. PCR was then used to test the relationship 
between P. falciparum infection and IFN- +874T/A gene polymorphism of the 
samples. The result of the nested PCR showed that out of 34 samples, 17 samples were 
malaria positive and P. falciparum positive, and 17 samples were negative. However, 
our result suggests that the IFN- +874T/A mutation has no association with P. 
falciparum infection. In conclusion, this data offers a starting point for functional and 
genetic analysis of the IFN-γ genomic region in malaria infection affecting Sudanese 
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1.1 Background of the study 
Malaria remains one of the significant public health problems due to its prominent 
high mortality and morbidity rate (Kosaisavee et al., 2011). Currently, it was estimated 
that about 216 million cases were recorded with 445 000 death worldwide in 2016. 
Unsurprisingly, the African region was representing the highest malaria cases, with 
90% episodes (WHO, 2017). In Sudan, the disease transmission rate was estimated to 
approximately 90% (Hamid et al., 2016; Niaz et al., 2018). Five different species of 
protozoan parasites named Plasmodium have been known to cause malaria in humans. 
P. falciparum cases were more frequent in the African region while P. vivax shows 
high frequencies in the Americas, South-East Asia, and Eastern Mediterranean 
Regions (Trampuz et al., 2003; Kosaisavee et al., 2011). The high transmission rate is 
mainly attributed to the spread of Anopheles mosquitos, particularly, Anopheles 
arabiansis (Niaz et al., 2018). 
 
Malaria has been associated with several clinical manifestations ranging from 
asymptomatic, mild (uncomplicated), and severe (complicated) illness, which often 
leads to death (Hamid et al., 2016). These conditions might be attributed to the genetic 
polymorphism, which can also be related to its ability to adapt to various geographical 
locations as well as different hosts (Mahgoub et al., 2012; Diering, 2018). Accordingly, 
WHO has taken into consideration the most vulnerable individuals as a prerequisite 
for prevention and treatment (WHO, 2017). These include infants and children with 
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the age of less than five years, pregnant women, and patients with HIV/AIDS (WHO, 
2017). 
 
The control of malaria infection is currently managed by chemoprophylaxis, 
which mounts the blood stage of malaria infection, thereby, preventing the malaria 
illness (WHO, 2017). However, with the appearance of drug resistance by P. 
falciparum for certain drugs have raised the requirement for the development of an 
effective vaccine for durable protection against malaria infection. Therefore, a quite 
appreciated attempt on this track has already been made to come out with a long-lasting, 
highly immunized as well as highly effective vaccine (Patel et al., 2017), but 
unfortunately, genetic polymorphisms within most vaccine candidate genes were the 
major obstacles toward achieving this goal (Gosling & von Seidlein, 2016; Campbell 
et al., 2017). Until now, there is still no approved vaccine available in the market, even 
though several potential vaccine candidates targeted against sporozoite, merozoite, and 
gametocyte stages of P. falciparum are now under various stages of clinical evaluation 
(Patel et al., 2017). 
 
Interferon gamma (IFN-γ) is a key immunological mediator that has a 
protective role in host defense against malaria but also contributes to underlying 
disease pathology. The target cells of IFN-γ during P. falciparum infection are 
monocytes/macrophages, neutrophils, Th2 cells and parasite-infected hepatocytes. 
IFN-γ also serves as a macrophage activating factor involved in the innate immune 
response to malaria. Activated macrophages release tumor necrosis factor α (TNF- ), 
transforming growth factor β (TGF-β), interleukins (IL)-1 and IL-6, and reactive 
oxygen and nitrogen radicals. Additionally, IFN-γ activates iNOS and induces the L-
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arginine dependent NO pathway via signal transducers associated with transcription. 
This NO pathway leads to the subsequent elimination of the infected hepatocytes 
(Elghazali et al., 1997). IFN-γ induces cellular activation by binding to a receptor 
complex - the interferon-gamma receptor (IFN-γR). IFN-γR is ubiquitously expressed 
on all monocytes, macrophages, T cells, B cells, NK cells, neutrophils, fibroblasts, and 
endothelial cells (Kwak, 2012). The receptor is a heterodimer of two subunits, α, and 
β, that are integral membrane proteins. Subunit α (IFN-γR1) is essential for IFN-γ 
binding, receptor trafficking, and signal transduction (Bach et al., 2003). At the same 
time, the β subunit (IFNγR2) functions as a transmembrane accessory factor. The 
heterodimeric IFNγR interacts with STAT1, GAF, JAK1, and/or JAK2 in the 
downstream IFN-γ signal transduction pathway (Samanez-Larkin et al., 2009). Several 
polymorphisms (SNPs and microsatellite repeat) from the promoter, introns, and UTR 
region of the IFN- gene have been reported (Koch et al., 2006). Some of these 
polymorphisms have been associated with diseases other than malaria (Wang et al., 
2012). A previous study also reported that several polymorphisms in the promoter 
region of IFN R1 affect gene regulation which will also influence the susceptibility to 
severe malaria (Koch et al., 2012). 
 
1.2 Significant of the study 
Malaria is one of the leading causes of death in Sudan. Although intensive control 
measures in recent years have resulted in a substantial reduction in disease burden, due 
to the violent conflict in Darfur, limited control options and resource availability 
maintain the high risk of malaria in displaced camps, making the disease responsible 
for most deaths. Therefore, more effective malaria control, like vaccination, is 
probably the best option. However, due to the complexity of malaria infection, until 
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now there is no disease vaccine available. Host genetic factors have been shown to 
influence intensity of malaria infection and clinical malaria, a very important factor in 
vaccine development. Several candidate genes were associated with severe malaria 
resistance, including IFN- , a Th1 cytokine known to help eliminate malaria parasites 
by enhancing macrophage phagocytic activity, generating intermediate reactive 
oxygen and L-arginine-derived nitric oxide, and stimulating T-cell proliferation. 
Several studies have reported associations between Interferon gamma (IFN-γ) (or also 
known as IFN G in some literatures) polymorphisms and susceptibility to disease. The 
first intron of the IFN-γ gene contains a highly polymorphic CA-repeat microsatellite, 
whose 12 CA-repeatallele is associated with high levels of IFN-γ production and has 
been associated with resistance or susceptibility to various diseases including malaria 
in other populations. However, very limited data can be found on the association of 
IFN-γ gene polymorphisms with P. falciparum infection in Sudanese population. 
Therefore, understanding the IFN-γ gene polymorphisms in Sudanese population is 
likely to be important for the future development of worldwide therapies and vaccine-
based interventions since IFN-γ stimulates Th1-type responses which are of 
parasitological importance in malaria elimination. 
 
1.3 Objectives of the study 
 
1.3.1 General objective 
To detect the IFN- γ gene polymorphism and Plasmodium falciparum infection in 





1.3.2 Specific objectives 
1. To determine malaria positive infection and P. falciparum identification in blood 
samples of malaria patients from Ardamata IDP Camp, Al-Geneina City, Sudan 
using nested polymerase chain reaction (nested PCR) 
 
2. To determine the association between IFN- gene polymorphism at single 
nucleotide +874T/A with P. falciparum infection in malaria patients of Ardamata 
IDP Camp, Al-Geneina City, Sudan 
 
1.4 Hypothesis 
1. Nested PCR confirmed that all the blood samples isolated from malaria patients 
of Ardamata IDP Camp, Al-Geneina City, Sudan are positive malaria and the 
infection is caused by P. falciparum. 
2. There is a positive association between IFN- gene polymorphism at single 
nucleotide +874T/A with P. falciparum infection in blood samples of malaria 




1.5 Flow chart of the study 
 
 


















































Malaria is one of the world's most serious infectious diseases. World Health Organization 
(WHO) reported 225 million malaria cases worldwide, with 781,000 deaths due to annual 
Plasmodium infection. Four species of Plasmodium are responsible for almost all human 
infections (P. falciparum, P. vivax , P. malariae and P. ovale) (Cavasini et al., 2000). 
Malaria parasites share the characteristic febrile episodes with their susceptibility to 
frequent intermittent paroxysms of chills, rigors, and sweating. They are also associated 
with many signs of other infectious diseases, including body aches, headache and nausea, 
general fatigue, and prostration. Untreated malaria infections are characterized by spleen 
enlargement. Serious, life-threatening conditions usually occur in P. falciparum malaria. 
These cause inflammation of vital organs during cerebral malaria including the lungs, 
kidneys, liver, and, most notably, the brain. Serious anemia can develop. These are the 
factors associated with the majority of acute malaria mortality. Chronic malaria infection 
can lead to nephrotic syndrome and this, too, can ultimately become fatal (Carter & 
Mendis, 2002). 
 
Repeated malaria attacks over several years due to any species of the parasites 
seriously damage body and mind. Cachexia and the splenic enlargement becomes a 
constant feature. The general definition of the disorder is lethargic and with sunken 
and sallow eyes, spindly limbs, and hard swollen belly. In this situation, the individual 
affected succumbs to illnesses or other difficulties that would scarcely endanger a 
normal healthy person. Under the burden of chronic malaria, both efficiency and 
lifespan are reduced considerably. However, an individual's malaria experience at a 
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given time is strongly influenced by the form and degree of antimalarial immunity he 
or she may have acquired (Deribew et al., 2017). 
 
2.1.1 Global malaria 
Malaria is endemic in regions of 107 countries, mainly in sub-Saharan Africa (Figure 
2.1). The spatial limits of distribution and seasonal activity are sensitive to climatic 
factors, as well as local disease control capability. In endemic areas where 
transmission occurs in regular, long-term seasons, fatality rates are highest among 
children who have not yet developed immunity to the disease. In epidemic areas where 
malaria transmission occurs in short seasons or in the form of epidemics, serious 
deaths are likely to occur in all age categories. After the Global Malaria Eradication 
Program launched by the World Health Organization (WHO) in the 1950s, 79 
countries eliminated malaria. Most of this progress has been made in the extratropics 
(Eurasia, North America, North Africa, and Australia) where malaria transmission has 
been highly seasonal due to temperate climate conditions and mainly due to P. vivax. 
In the early 1970s, WHO abandoned the idea of eliminating malaria in the tropics, 
particularly in Africa, due to deficiencies in local public health services. It was then 
replaced by a control policy using new control measures such as vector control through 
insecticide spraying, use of bed nets, systematic early detection and treatment of cases. 
Between 2000 and 2010, the incidence of malaria decreased by 17% worldwide and 
by 33% in African regions. There were 655,000 reported malaria deaths in 2010, of 
which 86% were children under the age of five. In 2010, the majority of malaria deaths 
occurred in Africa (91% of the global burden). They were due to P. falciparum (98% 











Measuring malaria mortality is a public health problem that was faced with 
different solutions. Outside Africa, these figures typically depend on government 
reported deaths, modified in different ways to compensate for insufficient coverage. 
Neeraj Dhingra and colleagues use the findings of verbal autopsies to predict malaria 
mortality in India. Non-medical field staff performed verbal autopsies for 122,291 
group deaths in 6,671 Indian sites between 2001 and 2003. Fieldworkers used verbal 
autopsies to determine fever cause and severity. Two qualified physicians coded the 
findings for death, and disputes were secretly adjudicated if there was no consensus. 
After adjudication, investigators reported that 3·6% of deaths between 1 month and 70 
years of age were malaria-related. Deaths initially attributed to malaria by one of the 
two physicians (3·8%) were used as a possible upper bound and those subsequently 
rated by both physicians were used as lower bound (1·7%) (Hay et al., 2011). 
 
2.1.2 Malaria in Sudan 
Malaria remains a major health problem in Sudan despite the efforts of the National 
Malaria Control Program (NMCP), with significant morbidity and mortality due to the 
emergence of resistance of P. falciparum parasite to chloroquine, especially in children 
under five. At about 44,000 deaths in 2002, it caused 9 million incidents, accounting 
for 20-40% of the overall outpatient attendance and about 40% of admissions. In 
addition, 2,877,000 disability-adjusted life-years (DALYs, which is a disease burden 
measure) lost in Sudan in 2002 due to malaria mortality (WHO, 2005; Abdalla et al., 
2007). Males face the highest pressure and mortality with more DALYs loses in 
females. The scope of malaria clinical presentation ranges from asymptomatic 
parasitemia, febrile fever, to serious potentially lethal disease in multiple transmission 
areas. It is due to factors such as parasite organisms and immune status of patients. 
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Severe malaria in Sudan is usually due to P. falciparum, however cases have also been 
described due to Plasmodium vivax (Mahgoub et al,, 2002). 
 
2.2 Malaria parasite 
Malaria is a mosquito-borne disease that affects several vertebrate species, including 
rodents, reptiles, birds, and primates. The infection is transmitted by the bite of an 
infected female Anopheles mosquito carrying a protozoan parasite of the genus 
Plasmodium. There are over 175 species of plasmodia currently recognized. Many of 
these are known to cause malaria in non-human vertebrates. However, human malaria 
can solely be caused by four Plasmodium species: P. vivax, P. ovale, P. malariae, and 
P. falciparum. Among these, P. falciparum is the most virulent and is responsible for 
almost all cases of severe disease and deaths. P. falciparum is the most common 
parasite in tropical Africa and exists in all malaria endemic regions worldwide while 
other species are variably distributed in different geographical locations. More than 
four hundred species of Anopheles were identified, but only seventy are known to 
transmit malaria to various vertebrates naturally. Human malaria parasites are 
transmitted by a few Anopheles species. A. gambiae, A. arabiensis, and A. funestus are 
the most prevalent in Africa. In contrast, other species such as A. albimanus, A. 




2.2.1 Life cycle of Plasmodium falciparum 
P. falciparum has a remarkably complex life cycle (Figure 2.2). The infection begins 
when sporozoites are released into the bloodstream by a female Anopheles mosquito. 
The inoculated sporozoites circulate before they invade the liver parenchymal cells, 
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where they undergo an asexual replicative phase called exo-erythrocytic schizogony. 
This liver stage of parasite lasts for approximately a week before releasing merozoites, 
which invade red blood cells (RBCs) (Siciliano & Alano, 2015). 
 
Erythrocyte invasion is crucial for parasite survival. It provides a rich source 
of nutrients in a niche (the parasitophorous) that is primarily protected from host 
immune defense. The erythrocytic schizogony involves rapid successive mitotic 
divisions and generates thousands of merozoites that are released to re-invade new 
erythrocytes. This stage is responsible for the acute clinical episodes of malaria (Wurtz 
et al., 2011). After a period of 7 to 15 days of asexual replicative cycles in RBCs, a 
small proportion of the merozoites transform into male and female gametocytes, the 
micro- and macro-gametocytes. The half-life of the mature gametocyte in the blood is 
about 2.4 days during which it could be taken up by a feeding Anopheles mosquito. A 
few minutes after the mosquito's ingestion, the micro-gametocytes exflagellate in the 
insect midgut, each forming eight micro-gametes that move to fertilize the female 
macro-gametes. Eighteen to 24 hours after fertilization, the zygote elongates into an 
ookinete, which traverses the membranes and the epithelial cells of the mid-gut and 
transforms into an oocyst. The oocyst enlarges progressively as the nucleus repeatedly 
divides to form sporozoites. Mature sporozoites exit the oocyst to the coelomic cavity 
and migrate to salivary glands awaiting transfer to a new victim (Talman et al., 
2010).Infectious mosquitoes inject sporozoites into the bloodstream of the human host, 
which then circulates through the blood to the liver. An exo-erythrocytic stage in the 
liver leads to merozoites escaping into the bloodstream. The merozoites invade the red 
blood cells and undergo an asexual replicative cycle (erythrocytic schizogony) to 
release several merozoites that can reinvade new red blood cells. Occasionally, 
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erythrocytic trophozoites turn into gametocytes that are released into the bloodstream 
(Talman et al., 2010). 
 
 
Figure 2.2: The life cycle of Plasmodium falciparum 
 







2.3 Immunity to malaria 
The immune system plays an important role in the host defense against P. 
falciparum infection and in reducing the severity of the disease once it occurs. 
While most people living in endemic areas of malaria are disproportionately 
exposed to infectious bites from the Anopheles mosquitoes, a substantial 
proportion of the infected individuals either cure the infection spontaneously or 
remain asymptomatic, i.e. harboring any parasitemia without serious clinical 
disease. A small number of infected people, mainly young children, experience 
clinical malaria symptoms, and only fewer than 5% of such clinical cases result in 
severe life-threatening complications (Rowe et al., 1995). The age-dependent 
development of immunity to malaria significantly affects malaria’s clinical pattern. 
Specific immune system components including antibody-dependent and cell-
mediated mechanisms operate at different stages of the life cycle of the parasite 
(Figure 2.2) (Branch et al., 2001). Protective immunity against malaria, however, 
takes years of exposure to infection before it improves dramatically, and even with 
frequent infections, this immunity is rarely sterile and is unique to the organisms, 
variants, strains, and level. This inefficient, sluggish development of anti-malaria 




2.3.1 Innate immunity to malaria 
Early interactions between sporozoites and host cells do not produce a significant 
systemic immune response and disease. The phases that elicit fast immuno-
inflammatory responses are just merozoites. While not well known, the defense 
against malaria included many humoral components against innate immunity 
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comprising the complement proteins, C-reactive proteins, and mannose-binding 
lectins. Nonetheless, the major inborn effector mechanisms against malaria 
parasites are regulated by cellular components, including monocyte-macrophages, 
natural killer cells, naturally occurring T-cells, and cells (Boldt et al., 2009). One 
of the first instances of innate resistance to P. falciparum infection is the activation 
of monocyte-macrophages. Infected red blood cells (iRBCs) are actively involved 
in phagocytosis and clearance of circulating monocytes and tissue-resident 
macrophages in the liver, spleen, and other tissues (Turrini et al., 2003). 
 
 
Malaria antigens, such as hemozoin pigment and membrane-anchored 
glycosylphosphatidylinositol, macrophages phagocytosis or surface receptor 
action, activate these cells to produce a series of pro-inflammatory mediators and 
cytokines. Inflammatory agents produced may have direct anti-parasite activity or 
may contribute to the activation of other immune mechanisms. However, these 
cells are also involved in severe malaria (Ferro et al., 2008). Natural killer T cells 
(NKTs) are a specialized subset of lymphocytes that share the properties of both T 
cells and NK cells. They differ from conventional T-cells in that; they express a 
distinct NK.1.1 marker and possess a unique single invariant Vш14 + antigen 
receptor that recognizes lipids and glycolipids presented by CD1d molecules rather 
than peptide-MHC complexes (Kinam Park, 2014). Experimental models have 
shown the role of NKTs in providing protection against murine malaria (Morris 
Jones et al., 1996). NKT cells were linked to malaria-associated splenomegaly and 
to the expansion of the splenic B cell pool forming a parasite-specific antibody 




Gamma/delta ( / ) T cells are a minor subset of T lymphocytes characterized 
by an antigen receptor formed by and chains rather than the common 5-007 and β 
chains that make up the antigen receptors in conventional T cells (Walker et al., 
2016). Peripheral / T  cells  are  strongly  regulated  during  malaria  and  respond  
to  malaria antigens through proliferation and lymphokine production. Activated 
γ/δ T-cells but not T-cells from malaria-naïve donors have been shown to inhibit 
parasite replication in erythrocytes in vitro, indicating an essential innate role 
protection against malaria (Morris Jones et al., 2018). Natural killer (NK) cells 
interact with iRBCs and release pro-inflammatory cytokines, particularly IFN- γ. 
In non-immune donors, NK cells may kill plasmodia-infected erythrocytes in the 
absence of opsonizing antibodies through direct cell-cell interaction. Early 
production of IFN-γ NK cells stimulated by IL-12 during malaria infection is 
associated with a better prognosis of the disease (Sam & Stevenson 2015). 
 
 
In addition, NK interaction with iRBCs induces the production of 
chemoattractant IL-8, suggesting the role of NK cells in the recruitment and 
activation of other leukocytes during malaria infection. Production of 
chemoattractant IL-8, suggesting the role of NK cells in the recruitment and 
activation of other leukocytes during malaria infection (Gardiner, 2014). Natural 
killer T cells (NKTs) are a specialized subset of lymphocytes that share the 
properties of both T cells and NK cells. They differ from conventional T-cells in 
that; they express a distinct NK.1.1 marker and possess a unique single invariant 
V5-00714 + antigen receptor that recognizes lipids and glycolipids presented by 





2.3.2 Adaptive immunity to malaria 
2.3.2(a) Anti-sporozoite immunity 
 
Malaria protection may be induced in animal models and humans following 
immunization with irradiated sporozoites. However, it confers complete resistance to 
subsequent sporozoite challenges; such protection is stage-specific and does not 
withstand problems with Plasmodium blood-stage. Anti-sporozoic antibodies are the 
main agents that promote phagocytosis and inhibit the invasion of hepatocytes 
(Mccutchan et al., 2014). These antibodies are primarily directed against the most 
abundant sporozoic surface proteins, circumsporozoic proteins (CSPs), 
thrombospondin-associated adhesive proteins (TRAPs), and several other sporozoic 
and liver-stage antigens. Most adults in malarious areas have been found to have a high 
titer of P. falciparum CSP antibodies and an immune sera from sporozoite-immunized 
human volunteers. Naturally, infected individuals have been found to block the 
invasion of hepatocytes by P. falciparum sporozoite (Berzins et al., 1986). 
 
2.3.2(b) Immunity to liver stages of malaria parasite 
Several cellular mechanisms are implicated in generating protective immunity 
against Plasmodium's liver stages (Connelly et al., 2004). T cells were shown to 
be involved in the generation of protective immunity in rodents immunized with 
irradiated sporozoites ). The passive transfer of CD8+ T cells and CD4+ T cells 
clones derived from sporozoite immunized mice was found to confer protection 
Cytotoxic T lymphocyte response to CS proteins was observed in field studies and 





2.3.2(C) Immunity to blood stages of malaria parasite 
The invasion of red cells is a crucial step in malaria infection and is the cause of clinical 
disease. Hence erythrocytic stages of P. falciparum are likely to be the most critical 
targets for protective immune responses. Protective immunity against erythrocytic 
stages involves antibody-dependent and cell-mediated immunity (Sanni et al., 2002). 
 
2.3.2(d) Antibody mediated immunity to blood stages of P. falciparum 
Passive transfer of anti-Plasmodium specific antibodies to non-immune mice and 
treatment of P. falciparum-infected patients with immunoglobulins isolated from 
normal immune individuals leads to a decrease in parasitemia and clinical symptoms 
(Nnedu et al., 2011). Moreover, studies in gene-targeted and B-cell-deficient mice 
have shown that B-cells are essential for the resolution of blood-stage murine malaria 
infections. Thus, protection from disease was thought to be primarily an antibody-
mediated response (Langhorne, 2012). In people living in endemic malaria areas, 
exposure to repeated infections with different variants of P. falciparum induces the 
production of polyclonal antibodies, predominantly IgM, IgG isotypes, and acquired 
malaria protective immunity correlates with age and the level of antibodies to asexual 
blood-stage parasite antigens. Consequently, a clinical episode in a child living in an 
endemic malaria zone represents an infection with a parasite that expresses VSA that 
is not recognized by the existing antibody repertoire (Maddison, 2016). 
 
 
3.3.2(e) Cell-mediated immunity to blood stages of P. falciparum 
Brown and co-workers made the first observations showing the importance of T 
lymphocytes in recovery from malaria infections in their thymectomized rat 
experiment (Brown et al., 2011). Later, it was shown that B-cell-deficient mice can be 
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immunized by natural Plasmodium infection and that the adoption of CD4
+
 T-cell 
clones could provide protection against malaria (Brown et al., 2002). However, as 
erythrocytes do not express MHC molecules, it seems unlikely that T cells could have 
direct cytotoxic effects on infected erythrocytes. Alternatively, it was suggested that T 
cells respond to malaria antigens by secreting cytokines. Consistent with this view, it 
has been shown that stimulation of T cells by malaria antigens presented by antigen-
presenting cells (APCs) results in the release of various cytokines. Gene-knocked-out 
mice experiments have shown that immune responses to the blood stages of 
Plasmodium are mostly mediated by T-lymphocytes (Plebanski et al., 2002). Both the 
Th1 and Th2 types of CD4
+
T cells were involved in the protection of malaria and 
pathogenesis in mice. It has been shown that, during the acute phase of the murine 
infection with Plasmodium chabaudi chabaudi AS, CD4
+
 T cells of the type Th1 
produced by IL-2 and IFN- are essential, whereas the type Th2 of these cells is required 
during the later stages to provide assistance to B-cells through IL-4 secretion (Taylor-
Robinson & Phillips, 2013). The secretion of IFN- by T lymphocytes is believed to 
induce cytophilic IgG blood-stage-specific antibodies and to aid in antibody-
dependent cellular inhibitor mechanisms (Taylor-Phillips, 1994). 
 
 
2.4 Immuno-pathogenesis of severe malaria 
Malaria is a very complicated disease. Several factors determine the clinical outcome 
of P. falciparum infection, including the intensity of parasite transmission, parasite 
virulence, multiple host genetic, nutritional, and immunological characteristics (Rowe 
et al., 1995; Idro et al., 2010). However, mechanisms leading to serious life-threatening 
complications of malaria are not fully understood (Rowe et al., 1995; Lundblom et al., 
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2013). The mechanisms underlying the pathogenesis of severe malaria remain 
controversial and several assumptions have been made to explain the cause of this 
deadly syndrome (Conroy et al., 2010; Lundblom et al., 2013). The mechanical 
(sequestration) hypothesis assumes that P. falciparum-parasitized erythrocytes bind to 
post capillary veneers, hindering blood flow, thereby reducing tissue perfusion and 
reducing waste disposal leading to brain pathology (Obradovic, 2005; Kunwittaya et 
al., 2014). Histological examination of brain sections of fatal cases of malaria revealed 
sequestration of iRBCs in multiple organs and tissues (MacKenzie et al., 2008). 
However, due to lack of sequestration in some patients with cerebral symptoms and 
the fact that most patients with malaria recover fully without evidence of ischaemic 
damage, the mechanical hypothesis cannot explain the cause of CM properly. 
Alternatively, it has been suggested that malaria toxins bind and stimulate monocytes 
to secrete pro-inflammatory cytokines (Stevenson & Ghadirian, 1989; Carter et al., 
2005). Although cytokines themselves are not harmful, they may induce the 
production of nitric oxide (NO), which spreads through the blood-brain barrier and 
interferes with the synaptic function as a general anesthetic, leading to a reduced state 
of consciousness (Craig et al., 2012). Several malaria antigens, such as membrane-
anchored glycosylphosphatidylinositol (GPI) and the by-product of parasite 
metabolism, hemozoin, may cause the release of cytokines from various host immune 
cells (Gallego-Delgado et al., 2015). Released cytokines up-regulate the expression of 
different endothelial adhesion receptors, such as ICAM-1, PECAM-1 / CD31, and thus 
enhance iRBC cyto-adhesion and sequestration (Bagot et al., 2002; Craig et al., 2012). 
Sequestered parasites in the brain vasculature may release more toxins locally and 




2.5 Role of cytokines in immuno-pathogenesis of malaria 
Cytokines have been shown to be critical molecular markers of cell-mediated 
immune response and are known to be key players in malaria control. Studies have 
shown that cytokines are associated differently with symptoms of disease, 
parasitemia, disease severity, and complications (Hechavarría et al., 2013). 
Effective proinflammatory cytokine response is needed to address parasitemia and 
control malaria infection (Freed-Pastor & Prives, 2012). In addition, enhanced 
IFN- levels have been seen as a surrogate marker for protection of childhood 
malaria (Fiore & et al., 2008). Increased TNF-5-007 stimulated phagocytosis and 
improved clearance of parasitized erythrocytes (Autino et al., 2012). 
 
On the other hand, proinflammatory cytokines appear to contribute to adverse 
disease outcomes as the prolonged and robust response of cytokines such as TNF-5-
007, IFN- , IL-8, and IL-18 has been associated with severe disease syndromes in both 
human and experimental models (Hansen & Schofield, 2010; Malaguarnera et al., 
2010). Severe malaria has been shown to be induced by IL-18 through IFN- production 
of Th1 cells and NK cells, primarily in the presence of IL-12 (Plant et al., 2001). 
Reduced plasma levels of TGF-β have been seen in Gabonese children with severe 
malaria (Malaguarnera et al., 2010; Perkins et al., 2011; Sawian et al., 2013). In 
contrast, higher TGF-β was observed under critical conditions of malaria in Burkina 
Faso (Berg et al., 2014;). A recent study in Fulani and non-Fulani ethnic groups in 
Mali showed that IL-1β was found at a high level while IL-10, a cytokine that limits 
the production of proinflammatory cytokines and chemokines seen during P. 
falciparum infection, was found to be low in Fulani compared to non-Fulani groups 
(Tatematsu et al., 2018). In the same area and from the same research group, Fulani 
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has been shown to have higher levels of several inflammatory cytokines compared to 
the non-Fulani ethnic group, in particular IFN-(McCall et al., 2010). 
 
Figure 2.3 shows the possible regulation of adaptive immunity to blood-stage 
malaria by cytokines produced by cells of the innate immune response. Maturation of 
DCs has associated with the upregulation of expression of MHC class II molecules, 
CD40, CD80, CD86 and adhesion molecules, and the production of cytokines 
including interleukin-12 (IL-12). IL-12 activates natural killer (NK) cells to produce 
IFN-γ and induces the differentiation of T helper 1 (TH1) cells. The production of 
cytokines, particularly IFN-γ, by NK cells, results in DC maturation. It enhances 
parasite-derived maturation stimuli, facilitating the clonal expansion of antigen-
specific naive CD4+ T cells. IL-2 produced by antigen-specific TH1 cells further 
activates NK cells to produce IFN-γ, which induces DC maturation and activates 
macrophages, further amplifying the adaptive immune response. Cytokines such as IL-
10 and transforming growth factor-β (TGF-β) negatively regulate both innate and 
adaptive responses. NO, nitric oxide; TCR, T-cell receptor; TNF, tumour-necrosis 





Figure 2.3: Linking innate and adaptive immunity to blood-stage malaria 





2.6 The role of IFN-γ in malaria disease 
IFN-γ (or sometimes also indicate as IFNG) secretion by innate and adaptive immune 
cells is essential for the control of various diseases including malaria. It is an essential 
cytokine in controlling Plasmodium infection in the liver and blood stages of the 
parasite life cycle. It can also exacerbate the severity of the malarial disease, depending 
on the temporal and spatial production of IFN-γ (King & Lamb, 2015; Rowe & Wright, 
2020). 
 
Plasmodium infection induces IFN-γ production from various innate and 
adaptive immune cell subsets at different stages of the life cycle (Figure 2.4). Various 
immune cell subsets produce IFN-γ in response to Plasmodium infection. NK, γδ, and 
NKT cells are primarily responsible for the early production of IFN-γ in response to 
the parasite's liver and blood stages and play a role in the first control of parasite 
growth. IFN-γ-producing CD8+ T cells have also been shown to limit intrahepatic 
parasite growth through an IFN-γ-inducible, nitric oxide-dependent mechanism 
(Sanches-Vaz et al., 2019). Once an adaptive immune response is initiated, IFN-γ 
produced by CD4+ T cells optimally activates CD8+ T cells, B cells, and macrophages. 
IFN-γ influences isotype switching in B cells leading to the production of cytophilic 
antibodies capable of binding free parasites and blocking red blood cell invasion (Nasr 
et al., 2014). Besides, this cytokine is also mediating parasite clearance through 
opsonization (Jagannathan et al., 2014) and binding the surface of infected red blood 
cells to promote antibody-dependent phagocytosis (King & Lamb, 2015). Production 
of IFN-γ from CD4+ T cells also optimally activates macrophages to phagocytose 
infected red blood cells and free parasites (Harawa et al., 2019). All of these 
mechanisms are important for optimal control of parasite growth during Plasmodium 
